Q

Queensland Eye Institute | Woolloongabba QEI Clinic, Woolloongabba, Australia

Research site

(Unclaimed)

Location

87 Ipswich Road, Woolloongabba, Queensland, Australia

Site insights

Top conditions

Top treatments

Ranibizumab

KIO-301

Faricimab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa (ABACUS-2)

The goal of the study is to investigate the safety, tolerability and efficacy of up to 3 doses of KIO-301 administered by intravitreal (IVT) injectio...

Not yet enrolling

Retinitis Pigmentosa

Drug: 100 μg KIO-301

Other: Placebo (Sterile Saline)

Status recently updated

A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual assessor-masked study designed to assess the efficacy, safety, and pharmacokin...

Enrolling

Active, not recruiting

Neovascular Age-related Macular Degeneration (nAMD)

Device: Port Delivery System with Ranibizumab

Drug: Ranibizumab